1. Home
  2. BRCC vs PBYI Comparison

BRCC vs PBYI Comparison

Compare BRCC & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRCC
  • PBYI
  • Stock Information
  • Founded
  • BRCC 2014
  • PBYI 2010
  • Country
  • BRCC United States
  • PBYI United States
  • Employees
  • BRCC N/A
  • PBYI N/A
  • Industry
  • BRCC Beverages (Production/Distribution)
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRCC Consumer Staples
  • PBYI Health Care
  • Exchange
  • BRCC Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • BRCC 202.4M
  • PBYI 167.3M
  • IPO Year
  • BRCC N/A
  • PBYI N/A
  • Fundamental
  • Price
  • BRCC $1.50
  • PBYI $3.35
  • Analyst Decision
  • BRCC Strong Buy
  • PBYI Strong Buy
  • Analyst Count
  • BRCC 4
  • PBYI 1
  • Target Price
  • BRCC $3.13
  • PBYI $7.00
  • AVG Volume (30 Days)
  • BRCC 506.0K
  • PBYI 409.0K
  • Earning Date
  • BRCC 08-06-2025
  • PBYI 07-31-2025
  • Dividend Yield
  • BRCC N/A
  • PBYI N/A
  • EPS Growth
  • BRCC N/A
  • PBYI 143.51
  • EPS
  • BRCC N/A
  • PBYI 0.77
  • Revenue
  • BRCC $383,072,000.00
  • PBYI $232,709,000.00
  • Revenue This Year
  • BRCC $6.16
  • PBYI N/A
  • Revenue Next Year
  • BRCC $11.09
  • PBYI N/A
  • P/E Ratio
  • BRCC N/A
  • PBYI $4.34
  • Revenue Growth
  • BRCC N/A
  • PBYI 2.68
  • 52 Week Low
  • BRCC $1.48
  • PBYI $2.23
  • 52 Week High
  • BRCC $7.14
  • PBYI $4.13
  • Technical
  • Relative Strength Index (RSI)
  • BRCC 30.68
  • PBYI 48.94
  • Support Level
  • BRCC $1.65
  • PBYI $3.53
  • Resistance Level
  • BRCC $1.76
  • PBYI $3.70
  • Average True Range (ATR)
  • BRCC 0.08
  • PBYI 0.18
  • MACD
  • BRCC -0.01
  • PBYI -0.01
  • Stochastic Oscillator
  • BRCC 0.00
  • PBYI 29.85

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. it is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: